Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Larixol

Product Specifications

UNSPSC Description

Larixol is an fMLP inhibitor and also inhibits Src kinase, ERK1/2, p38 and AKT phosphorylation signals in immune regulation. Larixol can interfere with the interaction between the βγ subunit of the fMLP receptor Gi protein and its downstream molecules, thereby inhibiting fMLP-induced respiratory burst. Larixol inhibits fMLP (0.1 μM)-induced superoxide anion production (IC50: 1.98 μM), cathepsin G release (IC50: 2.76 μM), and chemotaxis. Larixol improves neutrophil hyperactivation and reduces inflammation or tissue damage. A series of Larixol derivatives were found to have inhibitory effects on FSGS-related TRPC6 functional mutants[1][2].

Target Antigen

Akt; ERK; Src

Type

Natural Products

Related Pathways

MAPK/ERK Pathway;PI3K/Akt/mTOR;Protein Tyrosine Kinase/RTK;Stem Cell/Wnt

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/larixol.html

Purity

95.52

Solubility

DMSO : 50 mg/mL (ultrasonic)

Smiles

C[C@]12[C@@](C(C)(CCC2)C)([H])[C@H](CC([C@@H]1CC[C@](C)(O)C=C)=C)O

Molecular Weight

306.48

References & Citations

[1]Liao HR, et al. Larixol inhibits fMLP-induced superoxide anion production and chemotaxis by targeting the βγ subunit of Gi-protein of fMLP receptor in human neutrophils. Biochem Pharmacol. 2022 Jul;201:115091.|[2]Urban N, et al. Pharmacological inhibition of focal segmental glomerulosclerosis-related, gain of function mutants of TRPC6 channels by semi-synthetic derivatives of larixol. Br J Pharmacol. 2017 Nov;174(22):4099-4122.

Shipping Conditions

Blue Ice

Storage Conditions

-20°C (Powder, sealed storage, away from moisture)

Product Datasheet

http://file.medchemexpress.com/batch_PDF/HY-W744699/Larixol-DataSheet-MedChemExpress.pdf

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-W744699/Larixol-SDS-MedChemExpress.pdf

Clinical Information

No Development Reported

CAS Number

1438-66-0

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

N, N-Bis (isopropyl) benzylamine
OR3756-01 1 g

N, N-Bis (isopropyl) benzylamine

Ask
View Details
N, N-Bis (isopropyl) benzylamine
OR3756-02 10 g

N, N-Bis (isopropyl) benzylamine

Ask
View Details
N, N-Bis (isopropyl) benzylamine
OR3756-03 25 g

N, N-Bis (isopropyl) benzylamine

Ask
View Details
ASCL4 Polyclonal Antibody
E914439 100ul

ASCL4 Polyclonal Antibody

Ask
View Details
PANK3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
35981061 1.0 µg DNA

PANK3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

Ask
View Details
TOPBP1 (Topoisomerase (DNA) II Binding Protein 1, TOP2BP1) (MaxLight 750)
MBS6241141-01 0.1 mL

TOPBP1 (Topoisomerase (DNA) II Binding Protein 1, TOP2BP1) (MaxLight 750)

Ask
View Details